Generic Drugs

Supreme Court Deals Blow To Big Pharma Over Little-Known ACA Provision

The Amgen headquarters in Thousand Oaks, Calif. (AP/Mark J. Terrill)
The Supreme Court dealt a blow to big pharma on Monday, ruling that companies making generic “biosimilars” to brand-name drugs don’t have to wait an extra six months after gaining federal approval before selling their drugs.
The ruling, written by Justice Clarence Thomas for the unanimous court, is expected to speed up how quickly generic drugs become available to consumers.

Big Pharma’s Pollution Is Creating Deadly Superbugs, While The World Looks The Other Way

A microbiologist works with tubes of bacteria samples in an antimicrobial resistance and characterization lab within the Infectious Disease Laboratory at the Centers for Disease Control and Prevention in Atlanta. (AP/David Goldman)
Industrial pollution from Indian pharmaceutical companies making medicines for nearly all the world’s major drug companies is fuelling the creation of deadly superbugs, suggests new research. Global health authorities have no regulations in place to stop this happening.

Study Finds Pharma Reps Influence Doctor Prescription Decisions

Doctors at teaching hospitals are more likely to prescribe generic drugs over name-brand ones when pharmaceutical sales representatives are kept at bay, a study published in JAMA shows. [1]
By comparison, doctors working in hospitals that don’t keep pharma sales reps on a short leash – freely accepting meals and gifts, and letting reps have free reign of the hospital – prescribed far more name-brand medications.